###begin article-title 0
Conditional, genetic disruption of ciliary neurotrophic factor receptors reveals a role in adult motor neuron survival
###end article-title 0
###begin p 1
Re-use of this article is permitted in accordance with the Creative Commons Deed, Attribution 2.5, which does not permit commercial exploitation.
###end p 1
###begin p 2
###xml 414 421 414 421 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 394 399 <span type="species:ncbi:10090">mouse</span>
###xml 546 550 <span type="species:ncbi:10090">mice</span>
###xml 746 751 <span type="species:ncbi:10090">mouse</span>
###xml 806 828 <span type="species:ncbi:272636">adeno-associated virus</span>
###xml 830 833 <span type="species:ncbi:272636">AAV</span>
###xml 928 933 <span type="species:ncbi:10090">mouse</span>
###xml 1081 1085 <span type="species:ncbi:10090">mice</span>
###xml 1114 1117 <span type="species:ncbi:272636">AAV</span>
Indirect evidence suggests that endogenous ciliary neurotrophic factor (CNTF) receptor signaling can promote motor neuron (MN) survival in the adult. If so, proper targeting of this signaling may selectively counteract the effects of adult MN diseases. However, direct evidence for CNTF receptor involvement in adult MN survival is lacking, presumably because the unconditional blockade of the mouse CNTF receptor in vivo [through genetic disruption of the essential CNTF receptor alpha (CNTFRalpha) gene] leads to uniform perinatal death of the mice. To overcome this limitation, we have developed a method to selectively disrupt CNTF receptor function in a targeted subset of adult MNs that are not required for survival. A 'floxed CNTFRalpha' mouse line was generated and characterized. In addition, an adeno-associated virus (AAV) vector that drives Cre recombinase (Cre) expression was constructed and shown, with reporter mouse lines, to selectively excise floxed genes in facial MNs following its stereotaxic injection into the facial motor nucleus. Adult floxed CNTFRalpha mice were then injected with the AAV-Cre vector to excise the CNTFRalpha gene in the targeted MNs. The resulting data indicate that adult CNTF receptor signaling, likely by the MNs themselves, can play an essential role in MN survival. The data further indicate that this role is independent of any developmental contributions CNTF receptor signaling makes to MN survival or function.
###end p 2
###begin title 3
Introduction
###end title 3
###begin p 4
###xml 111 131 111 131 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b35">White &amp; Krause, 1993</xref>
###xml 133 163 133 163 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b3">Cuevas &amp; Gimenez-Gallego, 1997</xref>
###xml 174 180 174 180 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 165 186 165 186 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b17">Kordower <italic>et al.</italic>, 2000</xref>
###xml 194 200 194 200 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 188 206 188 206 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b27">Ozawa <italic>et al.</italic>, 2000</xref>
###xml 630 637 630 637 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 150 157 <span type="species:ncbi:558547">Gallego</span>
Indirect data suggest that endogenous growth factor mechanisms have evolved to promote neuronal survival (e.g. White & Krause, 1993; Cuevas & Gimenez-Gallego, 1997; Kordower et al., 2000; Ozawa et al., 2000). Like endogenous pain control systems, these mechanisms are not completely effective, given that insults such as trauma and disease can still have devastating effects. However, selective enhancement of these mechanisms, to harness their evolved power and specificity, may lead to valuable therapies. Development of such targeted interventions will require a better understanding of how these mechanisms naturally function in vivo.
###end p 4
###begin p 5
###xml 123 131 123 131 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 141 147 141 147 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 133 153 133 153 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b19">Lindsay <italic>et al.</italic>, 1994</xref>
###xml 156 164 156 164 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vivo,</italic>
###xml 252 258 252 258 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 243 264 243 264 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b31">Sendtner <italic>et al.</italic>, 1990</xref>
###xml 309 315 309 315 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 300 321 300 321 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b32">Sendtner <italic>et al.</italic>, 1992</xref>
###xml 329 335 329 335 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 323 341 323 341 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b14">Ikeda <italic>et al.</italic>, 1995</xref>
###xml 349 355 349 355 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 343 361 343 361 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b30">Sagot <italic>et al.</italic>, 1995</xref>
###xml 367 373 367 373 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 363 379 363 379 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b28">Pun <italic>et al.</italic>, 2006</xref>
###xml 447 453 447 453 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 437 459 437 459 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b26">Oppenheim <italic>et al.</italic>, 1991</xref>
Ciliary neurotrophic factor (CNTF) is one of the most potent neuroprotective factors for developmental motor neurons (MNs) in vitro (Lindsay et al., 1994). In vivo, exogenously administered CNTF protects MNs following early postnatal axotomy (Sendtner et al., 1990), in genetic models of MN disease (Sendtner et al., 1992; Ikeda et al., 1995; Sagot et al., 1995; Pun et al., 2006), and during developmental naturally occurring MN death (Oppenheim et al., 1991). These pharmacological data raise the promising possibilities that endogenous CNTF receptor signaling may promote MN survival and that manipulating this signaling may be a valuable tool in the treatment of adult MN diseases.
###end p 5
###begin p 6
###xml 136 142 136 142 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 129 148 129 148 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b23">Miller <italic>et al.</italic>, 1996</xref>
###xml 333 340 333 340 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 491 497 491 497 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 483 503 483 503 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b12">Helgren <italic>et al.</italic>, 1994</xref>
###xml 814 820 806 812 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 808 827 800 819 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b4">Davis <italic>et al.</italic>, 1993a</xref>
###xml 945 951 937 943 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 938 957 930 949 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b29">Saggio <italic>et al.</italic>, 1995</xref>
###xml 1006 1012 998 1004 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 1003 1018 995 1010 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b18">Li <italic>et al.</italic>, 1995</xref>
However, amyotrophic lateral sclerosis (ALS) trials with systemic CNTF injections were stopped due to unacceptable side effects (Miller et al., 1996), indicating that any manipulation of CNTF signaling in MN diseases will need to be more specifically targeted. Unfortunately, it is not known where exogenous CNTF acts to protect MNs in vivo. Evidence suggests that the effect need not directly involve MN CNTF receptors. For instance, skeletal muscle CNTF receptors maintain muscle (Helgren et al., 1994), thereby raising the possibility that the CNTF indirectly promotes MN survival by maintaining muscle-derived MN survival factor(s). The CNTF may also promote MN survival by increasing muscle-derived, soluble CNTF/CNTF receptor alpha (CNTFRalpha) complexes that could enhance MN CNTF receptor signaling (Davis et al., 1993a). In addition, CNTF, at the concentrations employed, can activate leukemia inhibitory factor (LIF) receptors (Saggio et al., 1995), which have been implicated in MN survival (Li et al., 1995).
###end p 6
###begin p 7
###xml 196 202 182 188 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 190 209 176 195 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b5">Davis <italic>et al.</italic>, 1993b</xref>
###xml 217 223 203 209 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 211 229 197 215 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b8">Elson <italic>et al.</italic>, 2000</xref>
###xml 239 245 225 231 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 231 251 217 237 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b7">Derouet <italic>et al.</italic>, 2004</xref>
###xml 356 362 338 344 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 347 368 329 350 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b6">DeChiara <italic>et al.</italic>, 1995</xref>
###xml 274 278 <span type="species:ncbi:10090">mice</span>
The CNTF receptor consists of CNTFRalpha, LIF receptor beta (LIFRbeta) and gp130, with CNTFRalpha being unique to CNTF receptors and required for all known forms of CNTF receptor signaling (Davis et al., 1993b; Elson et al., 2000; Derouet et al., 2004). CNTFRalpha knockout mice uniformly die within 24 h of birth, with a 30-50% reduction in MNs (DeChiara et al., 1995), indicating that endogenous CNTF receptor signaling is essential for embryonic MN survival/development. However, it is not known whether: (i) this reflects an embryonic function of CNTF receptors that is not required in the adult; and (ii) this results from loss of CNTF receptor signaling in MNs or other cell types. These are critical issues for the development of CNTF receptor-related therapeutics because most MN disease symptoms initiate in adulthood and the next generation of treatments will need to be designed to reduce side effects by targeting specific cell types. The present study employed adult-onset CNTFRalpha gene disruption in MNs to directly address these questions.
###end p 7
###begin title 8
Materials and methods
###end title 8
###begin title 9
###xml 0 5 <span type="species:ncbi:10090">Mouse</span>
Mouse lines
###end title 9
###begin p 10
###xml 82 85 78 81 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lox</italic>
###xml 149 155 145 151 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 141 161 137 157 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b34">Wattler <italic>et al.</italic>, 1999</xref>
###xml 204 208 <span type="species:ncbi:10090">Mice</span>
###xml 408 412 <span type="species:ncbi:10090">mice</span>
###xml 473 478 <span type="species:ncbi:9606">Women</span>
Exons 3-5 of the CNTFRalpha gene ('exon1' containing start codon) were flanked by lox P sites ('floxed') using previously described methods (Wattler et al., 1999), through contract with Lexicon Genetics. Mice, maintained on a 129/SvEvBrd background, were produced by heterozygote x heterozygote crosses and genotyped by Southern blot or polymerase chain reaction analysis of tail biopsy DNA. ROSA26 and Z/EG mice from Jackson Laboratories and Corrinne Lobe (Sunnybrook and Women's College, Toronto, Canada), respectively, were backcrossed onto the 129SvEvBrd background. Animal procedures were approved by the University of Cincinnati IACUC in accordance with NIH guidelines.
###end p 10
###begin title 11
###xml 0 22 <span type="species:ncbi:272636">Adeno-associated virus</span>
###xml 24 27 <span type="species:ncbi:272636">AAV</span>
Adeno-associated virus (AAV)-Cre recombinase (Cre)
###end title 11
###begin p 12
###xml 96 102 96 102 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 85 108 85 108 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b36">Zolotukhin <italic>et al.</italic>, 1999</xref>
###xml 365 366 362 363 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">8</sup>
###xml 446 447 442 443 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7</sup>
###xml 0 22 <span type="species:ncbi:272636">Adeno-associated virus</span>
###xml 24 27 <span type="species:ncbi:272636">AAV</span>
###xml 111 115 <span type="species:ncbi:10090">Mice</span>
###xml 350 353 <span type="species:ncbi:272636">AAV</span>
###xml 430 433 <span type="species:ncbi:272636">AAV</span>
###xml 488 491 <span type="species:ncbi:272636">AAV</span>
Adeno-associated virus (AAV)-Cre was generated with previously described procedures (Zolotukhin et al., 1999). Mice were anesthetized with ketamine/xylazine i.p. and received aseptic, bilateral stereotaxic facial nuclei injections (coordinates from Bregma: AP -5.5, ML +/- 1.1, DV -5.7) with a 33-guage Hamilton needle. Each side received 1.5 muL of AAV-Cre [1 x 108 infectious particles/muL in phosphate-buffered saline (PBS) = 'AAV-Cre'; 1 x 107 infectious particles/muL in PBS = '1/10 AAV-Cre'] or PBS at 0.25 muL/min (with 1 min between each 0.25 muL injected and a 10-min wait before needle removal).
###end p 12
###begin title 13
Anatomical procedures
###end title 13
###begin p 14
###xml 425 431 424 430 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 415 437 414 436 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b21">MacLennan <italic>et al.</italic>, 1996</xref>
###xml 491 497 486 492 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 481 503 476 498 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b21">MacLennan <italic>et al.</italic>, 1996</xref>
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice were overdosed with Avertin and transcardially perfused with cold saline followed by 4% para formaldehyde (PFA). Brains were post-fixed overnight in 4% PFA followed by cyroprotection in 30% sucrose with 2.5 mM sodium azide. Coronal, cryostat sections (30 mum) from throughout the facial nucleus were stained with either Cresyl violet (CV), standard Xgal histology or previously described immunohistochemistry (MacLennan et al., 1996). Antibodies recognizing CNTFRalpha ('3x'; MacLennan et al., 1996), green fluorescent protein (GFP; Millipore, Temecula, CA, USA) or Cre (Covance, Denver, PA, USA) were visualized through either ABC amplification (Vector Laboratories, Burlingame, CA, USA) and cyanine-3 tyramide (Perkin-Elmer, Waltham, MA, USA), or AlexaFluor-conjugated secondaries (Invitrogen, Carlsbad, CA, USA).
###end p 14
###begin title 15
MN counting
###end title 15
###begin p 16
###xml 117 118 117 118 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">z</italic>
###xml 225 231 225 231 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 219 237 219 237 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b13">Hyman <italic>et al.</italic>, 1998</xref>
###xml 239 266 239 266 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b11">Hatton &amp; Von Bartheld, 1999</xref>
###xml 672 673 672 673 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 720 725 720 725 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">anova</sc>
###xml 749 757 749 757 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">post hoc</italic>
###xml 403 407 <span type="species:ncbi:10090">mice</span>
Cresyl violet-stained facial MNs were counted in every fourth section. To correct for cells potentially split in the z-dimension, all neurons in focus at the top border of the sections were excluded (optical dissector; Hyman et al., 1998; Hatton & Von Bartheld, 1999). Counts were multiplied by four to estimate total MNs ('fractionator'). This procedure was validated by counting all facial MNs in two mice and obtaining values, in each case, that were within 3% of the fractionator estimate. As with all processing and analysis, MN counting was conducted by individuals unaware of experimental conditions, including genotype. Statistical analysis consisted of Student's t-tests (when only two groups were involved) or anova followed by Bonferroni post hoc tests.
###end p 16
###begin title 17
Results
###end title 17
###begin title 18
###xml 38 42 <span type="species:ncbi:10090">mice</span>
Characterization of floxed CNTFRalpha mice
###end title 18
###begin p 19
###xml 200 206 188 194 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 191 212 179 200 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b6">DeChiara <italic>et al.</italic>, 1995</xref>
###xml 283 294 271 282 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b2">Bazan, 1990</xref>
###xml 809 815 785 791 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 800 821 776 797 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b6">DeChiara <italic>et al.</italic>, 1995</xref>
###xml 906 912 882 888 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig04">Fig. 4</xref>
###xml 960 963 936 939 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lox</italic>
###xml 18 22 <span type="species:ncbi:10090">mice</span>
###xml 328 332 <span type="species:ncbi:10090">mice</span>
###xml 365 369 <span type="species:ncbi:10090">mice</span>
###xml 470 474 <span type="species:ncbi:10090">mice</span>
###xml 505 509 <span type="species:ncbi:10090">mice</span>
###xml 614 618 <span type="species:ncbi:10090">mice</span>
###xml 794 798 <span type="species:ncbi:10090">mice</span>
###xml 835 839 <span type="species:ncbi:10090">mice</span>
Floxed CNTFRalpha mice were generated in which Cre-induced removal of the targeted sequence functionally inactivates the CNTFRalpha gene, based on both the unconditional CNTFRalpha knockout (DeChiara et al., 1995) and structure-function relationships for related cytokine receptors (Bazan, 1990). Matings of heterozygote floxed mice yielded 24.7% homozygous floxed mice (i.e. 53 of 215; not significantly different from predicted Mendelian frequency). Homozygous floxed mice (referred to simply as floxed mice here) survive with no apparent abnormalities or decrease in CNTFRalpha expression relative to wild-type mice. Moreover, while embryonic MN survival/development is highly dependent on CNTFRalpha function, as demonstrated by the loss of these cells in unconditional CNTFRalpha knockout mice (DeChiara et al., 1995), the floxed mice display no loss of MNs, even at several months of age (see below; Fig. 4). Therefore, as expected, the insertion of the lox P sites into introns of the CNTFRalpha gene has no noticeable effect on CNTFRalpha function.
###end p 19
###begin p 20
###xml 305 306 295 296 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</italic>
###xml 390 391 380 381 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 402 403 392 393 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 492 505 482 483 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8225;</sup>
###xml 505 506 483 484 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 0 22 <span type="species:ncbi:272636">Adeno-associated virus</span>
###xml 24 27 <span type="species:ncbi:272636">AAV</span>
###xml 112 116 <span type="species:ncbi:10090">mice</span>
###xml 264 268 <span type="species:ncbi:10090">mice</span>
Adeno-associated virus (AAV)-Cre recombinase (Cre) injection into the facial motor nucleus of floxed CNTFRalpha mice leads to genotype-dependent loss of facial MNs. The mean (+/-SEM) number of facial MNs in wild-type (open bars) and floxed CNTFRalpha (solid bars) mice following the indicated treatments. N per condition presented in bars. Less than identically treated wild-type controls *P < 0.05; **P < 0.001; less than vehicle (phosphate-buffered saline; PBS)-injected wild-type controls double daggerP < 0.01.
###end p 20
###begin p 21
###xml 220 226 216 222 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig01">Fig. 1</xref>
###xml 393 399 389 395 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 524 530 516 522 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 515 536 507 528 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b6">DeChiara <italic>et al.</italic>, 1995</xref>
###xml 20 24 <span type="species:ncbi:10090">mice</span>
###xml 112 116 <span type="species:ncbi:10090">mice</span>
###xml 288 292 <span type="species:ncbi:10090">mice</span>
###xml 454 458 <span type="species:ncbi:10090">mice</span>
Crossing the floxed mice with a 'deleter' line that produces floxed gene excision in all cells (protamine 1-Cre mice) resulted in: (i) Southern bands corresponding to the designed Cre-dependent CNTFRalpha gene excision (Fig. 1); (ii) the expected perinatal death of all homozygous floxed mice, but not heterozygous or wild-type littermates; and (iii) the expected loss (approximately 30%; Lee et al., preliminary data) of facial MNs in homozygous floxed mice, all as seen with universal CNTFRalpha gene disruption (DeChiara et al., 1995).
###end p 21
###begin p 22
###xml 72 76 <span type="species:ncbi:10090">mice</span>
###xml 105 109 <span type="species:ncbi:10090">mice</span>
###xml 141 145 <span type="species:ncbi:10090">mice</span>
Cre expression leads to CNTFRalpha gene disruption in floxed CNTFRalpha mice. Breeding floxed CNTFRalpha mice with protamine-1-Cre 'deleter' mice leads to the designed excision of floxed CNTFRalpha sequence as indicated by Southern blot bands of predicted size (DNA from tail biopsies). Wild-type (lane 1), homozygous floxed (lane 2), heterozygous floxed (lane 3) and progeny of a heterozygous excised x heterozygous excised cross (lanes 4-10). ex, excised; flx, floxed; wt, wild-type.
###end p 22
###begin title 23
###xml 14 17 <span type="species:ncbi:272636">AAV</span>
A recombinant AAV vector excising floxed gene sequence in adult MNs
###end title 23
###begin p 24
###xml 65 72 65 72 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig02">Fig. 2A</xref>
###xml 262 276 262 276 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b24">Muzyczka, 1992</xref>
###xml 3 6 <span type="species:ncbi:272636">AAV</span>
###xml 56 59 <span type="species:ncbi:272636">AAV</span>
###xml 75 78 <span type="species:ncbi:272636">AAV</span>
###xml 287 290 <span type="species:ncbi:272636">AAV</span>
An AAV-2 vector driving Cre expression was constructed (AAV-Cre; Fig. 2A). AAV-2 vectors efficiently transduce neurons leading to long-term, vector-directed expression while eliciting little if any immune response, presumably due to the lack of any viral genes (Muzyczka, 1992). Because AAV-Cre is unable to replicate, Cre is expressed specifically in cells transduced by the injected virus particles.
###end p 24
###begin p 25
###xml 442 445 436 439 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 845 852 839 846 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="SD1">Figs S1</xref>
###xml 853 855 847 849 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="SD4">S4</xref>
###xml 1132 1139 1126 1133 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="SD5">Fig. S5</xref>
###xml 1187 1190 1181 1184 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 1498 1501 1492 1495 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 21 24 <span type="species:ncbi:272636">AAV</span>
###xml 100 103 <span type="species:ncbi:272636">AAV</span>
###xml 170 173 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 174 181 <span type="species:ncbi:9031">chicken</span>
###xml 230 239 <span type="species:ncbi:9995">woodchuck</span>
###xml 303 309 <span type="species:ncbi:9986">rabbit</span>
###xml 413 416 <span type="species:ncbi:272636">AAV</span>
###xml 455 459 <span type="species:ncbi:10090">mice</span>
###xml 474 477 <span type="species:ncbi:272636">AAV</span>
###xml 1084 1087 <span type="species:ncbi:272636">AAV</span>
###xml 1200 1205 <span type="species:ncbi:10090">mouse</span>
###xml 1229 1232 <span type="species:ncbi:272636">AAV</span>
###xml 1424 1427 <span type="species:ncbi:272636">AAV</span>
###xml 1473 1476 <span type="species:ncbi:272636">AAV</span>
###xml 1514 1518 <span type="species:ncbi:10090">mice</span>
Facial motor nucleus AAV-Cre injection leads to excision of floxed gene sequence in facial MNs. (A) AAV-Cre vector containing a Cre-IRES element-GFP cassette driven by a CMV/chicken beta-actin (CBA) promoter and incorporating the woodchuck post-transcriptional regulatory element (WPRE) followed by the rabbit beta-globin polyadenylation signal. The whole cassette is flanked by terminal repeat sequences (TR) of AAV-2. (B and C) Adult ROSA26+/- reporter mice injected with AAV-Cre 2 weeks prior to perfusion and Xgal histology. The blue reaction product indicating floxed gene excision is primarily confined to facial MNs [e.g. the cluster of large cells in the bottom center of (B) and in the CV counterstained section in (C)]. Higher magnification indicates that the many small blue specks result from labeling of MN processes (supplementary Figs S1-S4). In contrast, gene excision in facial nucleus astrocytes, through a GFAP-Cre gene construct, does not produce the many small blue specs, but clearly labels CV-stained small cells (presumptive astrocytes) that are not seen with AAV-Cre injection of the nucleus (supplementary Fig. S5). (D) GFP immunohistochemistry of an adult Z/EG+/- reporter mouse perfused 2 weeks after AAV-Cre injection. The reporter signal is once again primarily confined to facial MNs (oval cluster of large cells). It is important to note that any GFP expression from the weak IRES element of AAV-Cre was undetectable in facial MNs following AAV-Cre injection of Z/EG-/- (wild-type) mice, even with GFP immunohistochemical enhancement. Scale bars: 100 mum (B); 50 mum (C); 75 mum (D).
###end p 25
###begin p 26
###xml 544 550 544 550 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig03">Fig. 3</xref>
###xml 676 682 676 682 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 667 688 667 688 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b1">Bartlett <italic>et al.</italic>, 1998</xref>
###xml 697 703 697 703 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 690 709 690 709 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b15">Kaspar <italic>et al.</italic>, 2002</xref>
###xml 717 723 717 723 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 711 729 711 729 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b16">Klein <italic>et al.</italic>, 2002</xref>
###xml 26 29 <span type="species:ncbi:272636">AAV</span>
###xml 90 94 <span type="species:ncbi:10090">mice</span>
###xml 495 498 <span type="species:ncbi:272636">AAV</span>
###xml 593 596 <span type="species:ncbi:272636">AAV</span>
###xml 644 647 <span type="species:ncbi:272636">AAV</span>
In initial pilot studies, AAV-Cre was injected into the facial nuclei of adult, wild-type mice. Cre was immunohistochemically detected in 1/2-2/3 of the MNs at 1-month post-injection. The expression was confined to the facial MNs and small, scattered subpopulations of other neurons along the needle tract. Almost all the facial MNs in or near sections with needle tracts expressed Cre, while progressively less MNs expressed Cre as the distance from the needle tract increased. This ability of AAV-Cre to very selectively infect neurons (e.g. Fig. 3) agrees with our experience using related AAV-2 vectors, and reports from other groups using AAV-2 constructs (e.g. Bartlett et al., 1998; Kaspar et al., 2002; Klein et al., 2002).
###end p 26
###begin p 27
###xml 21 24 <span type="species:ncbi:272636">AAV</span>
Facial motor nucleus AAV-Cre injection leads to MN-selective expression of Cre. Facial MNs immunohistochemically labeled for expression of either the MN marker, choline acetyltransferase (red in A) or the neuronal marker, NeuN (red in B), and Cre (green in both A and B; yellow where both signals are approximately balanced). The Cre is found in the MNs, consistent with the reporter data. Arrows designate MNs with higher levels of Cre immunoreactivity, while arrowheads designate MNs with lower levels. Scale bars: 10 mum (A); 15 mum (B).
###end p 27
###begin p 28
###xml 171 184 171 184 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b33">Soriano, 1999</xref>
###xml 211 217 211 217 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 205 223 205 223 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b25">Novak <italic>et al.</italic>, 2000</xref>
###xml 364 373 364 373 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig02">Fig. 2B&#8211;D</xref>
###xml 873 880 873 880 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="SD1">Figs S1</xref>
###xml 881 883 881 883 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="SD5">S5</xref>
###xml 981 988 981 988 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="SD5">Figs S5</xref>
###xml 993 995 993 995 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="SD6">S6</xref>
###xml 90 94 <span type="species:ncbi:10090">mice</span>
###xml 165 169 <span type="species:ncbi:10090">mice</span>
###xml 199 203 <span type="species:ncbi:10090">mice</span>
###xml 537 540 <span type="species:ncbi:272636">AAV</span>
###xml 1014 1018 <span type="species:ncbi:10090">mice</span>
###xml 1045 1048 <span type="species:ncbi:272636">AAV</span>
###xml 1083 1087 <span type="species:ncbi:10090">mice</span>
To confirm that the Cre can excise floxed gene sequence in infected MNs, we used reporter mice in which active Cre leads to expression of beta-galactosidase (ROSA26 mice; Soriano, 1999) or GFP (Z/EG mice; Novak et al., 2000). Both reporter signals were present in 1/2-2/3 of the facial MNs, and scattered neurons along the needle tract, by 2 weeks post-injection (Fig. 2B-D). The same fraction of MNs was also reporter-positive at 1 month post-injection (data not shown) suggesting that, as expected, essentially all MNs infected by the AAV-Cre injection are infected and expressing active levels of Cre by 2 weeks post-injection. As with the Cre immunohistochemistry, the percentage of MNs labeled in any given section was dependent on the section's proximity to the needle tract. No reporter signals were observed in: (i) non-neuronal cells [e.g. Supplementary material, Figs S1-S5 (note: both reporters can detect Cre activity in all non-neuronal cell types; e.g. supplementary Figs S5 and S6)]; (ii) wild-type mice identically injected with AAV-Cre; or (iii) uninjected reporter mice (data not shown).
###end p 28
###begin title 29
CNTFRalpha-dependent survival of adult facial MNs
###end title 29
###begin p 30
###xml 85 91 85 91 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig04">Fig. 4</xref>
###xml 114 117 114 117 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lox</italic>
###xml 79 83 <span type="species:ncbi:10090">mice</span>
###xml 185 189 <span type="species:ncbi:10090">mice</span>
###xml 244 248 <span type="species:ncbi:10090">mice</span>
###xml 360 364 <span type="species:ncbi:10090">mice</span>
There was no floxed vs. wild-type difference in facial MN number in uninjected mice (Fig. 4), consistent with the lox P sites not interfering with CNTFRalpha gene function. These naive mice were all 7 months old when killed, while the injected mice described below ranged from 3 to 7 months old. Therefore, the floxed vs. wild-type differences in the injected mice do not reflect a differential age-related loss of MNs.
###end p 30
###begin p 31
###xml 401 407 397 403 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig04">Fig. 4</xref>
###xml 501 507 497 503 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig04">Fig. 4</xref>
###xml 755 761 747 753 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig04">Fig. 4</xref>
###xml 884 890 876 882 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig04">Fig. 4</xref>
###xml 1022 1028 1014 1020 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 1013 1034 1005 1026 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b20">Loonstra <italic>et al.</italic>, 2001</xref>
###xml 1043 1049 1035 1041 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 1036 1055 1028 1047 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b15">Kaspar <italic>et al.</italic>, 2002</xref>
###xml 42 46 <span type="species:ncbi:10090">mice</span>
###xml 125 128 <span type="species:ncbi:272636">AAV</span>
###xml 224 227 <span type="species:ncbi:272636">AAV</span>
###xml 305 309 <span type="species:ncbi:10090">mice</span>
###xml 521 524 <span type="species:ncbi:272636">AAV</span>
###xml 666 669 <span type="species:ncbi:272636">AAV</span>
###xml 693 697 <span type="species:ncbi:10090">mice</span>
###xml 749 753 <span type="species:ncbi:10090">mice</span>
Facial nuclei of adult, floxed CNTFRalpha mice and age-matched (generally littermate), wild-type controls were injected with AAV-Cre or the PBS vehicle, and were perfused 1 week, 2 weeks or 1 month later. While no effect of AAV-Cre injection was observed at 1 or 2 weeks post-injection, at 1 month floxed mice contained significantly less facial MNs than the identically injected, wild-type controls (Fig. 4). In contrast, no floxed vs. wild-type difference was detected in vehicle-injected controls (Fig. 4). Therefore, AAV-Cre, which excises floxed genes in the MNs, leads to preferential loss of MNs containing floxed CNTFRalpha genes. At 1 month post-injection, AAV-Cre-injected wild-type mice contained less MNs than vehicle-injected wild-type mice (Fig. 4). Although not statistically significant at this time point, this effect reached significance by 4 months post-injection (Fig. 4). These results are consistent with previous reports of cellular toxicity associated with long-term exposure to Cre (e.g. Loonstra et al., 2001; Kaspar et al., 2002). As discussed below, they raise the interesting possibility that endogenous CNTF receptor signaling may promote the survival of MNs challenged by insult.
###end p 31
###begin p 32
###xml 312 313 308 309 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 343 344 337 338 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 374 375 366 367 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 875 876 865 866 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 906 907 894 895 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 1104 1105 1090 1091 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 1133 1134 1117 1118 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 1141 1142 1125 1126 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1157 1170 1141 1154 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig05">Fig. 5A and B</xref>
###xml 38 42 <span type="species:ncbi:10090">mice</span>
###xml 85 88 <span type="species:ncbi:272636">AAV</span>
###xml 772 776 <span type="species:ncbi:10090">mice</span>
###xml 1005 1009 <span type="species:ncbi:10090">mice</span>
###xml 1231 1235 <span type="species:ncbi:10090">mice</span>
###xml 1594 1598 <span type="species:ncbi:10090">mice</span>
Cre immunohistochemistry of wild-type mice perfused 1 week, 2 weeks or 1 month after AAV-Cre injection indicated that Cre expression rises in infected facial MNs during this period such that by 1 month post-injection about half of the MNs expressed detectable levels of Cre [366 +/- 75 (mean +/- SEM) at 1 week (n = 6); 470 +/- 45 at 2 weeks (n = 6); 990 +/- 75 at 1 month (n = 4)]. Comparison of these data to the reporter results (above) suggests that, while the reporters are more sensitive than the Cre immunohistochemistry at detecting the low-level Cre expression at 2 weeks post-injection, most, and possibly all, infected MNs eventually display both Cre immunohistochemical and reporter indicators by 1 month post-injection. At 1 and 2 weeks post-injection floxed mice displayed the same number of Cre-positive facial MNs as wild-type controls [351 +/- 41 at 1 week (n = 6); 468 +/- 72 at 2 weeks (n = 6)]. However, at the 1 month interval, when MN death is first detected (see above), the floxed mice displayed a 68% decrease in Cre-positive MNs relative to the controls [wild-type: 990 +/- 75 (n = 4); floxed: 322 +/- 102 (n = 4); P < 0.002; e.g. Fig. 5A and B]. The number of Cre-negative facial MNs in the same 1-month mice was calculated by subtracting the number of Cre-positive facial MNs from the number of total facial MNs obtained from counting CV-stained sections. In contrast to the number of Cre-positive MNs, the number of Cre-negative MNs was unaffected (wild-type: 618 +/- 292; floxed: 734 +/- 138), indicating that Cre-expressing MNs are selectively lost in the floxed mice.
###end p 32
###begin p 33
###xml 39 42 <span type="species:ncbi:272636">AAV</span>
###xml 126 130 <span type="species:ncbi:10090">mice</span>
###xml 154 157 <span type="species:ncbi:272636">AAV</span>
###xml 454 458 <span type="species:ncbi:10090">mice</span>
###xml 645 648 <span type="species:ncbi:272636">AAV</span>
Cre and CNTFRalpha in facial MNs after AAV-Cre injection. Cre immunohistochemistry of wild-type (A) and floxed CNTFRalpha (B) mice perfused 1 month after AAV-Cre facial motor nucleus injection. Nuclear counterstaining (not shown) indicates that the label is primarily in the nuclei of the facial MNs (e.g. arrows), some of which are only partially in the plane of section. The examples illustrate the lower number of Cre-positive MNs remaining in floxed mice. Insets present arrowed nuclei at higher magnification. Broken lines delineate approximate facial motor nucleus borders. (C-H) While most Cre-expressing floxed MNs die by 4 months after AAV-Cre administration, almost all of the remaining few display no significant CNTFRalpha immunoreactivity (i.e. labeling equivalent to no primary antibody). CNTFRalpha immunohistochemistry (C, E, G) combined with Cre immunohistochemistry (D, F, H). Arrows designate Cre-positive wild-type (C and D) and floxed (E-H) MNs. Unlike the non-specific speckled Cre background, which does not correspond to cells, the larger and more intense Cre signals (arrows) correspond to MN nuclei. Scale bars: 100 mum (A and B); 25 mum (C-H).
###end p 33
###begin p 34
###xml 311 312 303 304 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 356 357 348 349 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 435 436 423 424 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 637 643 617 623 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig06">Figs 6</xref>
###xml 648 649 628 629 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig07">7</xref>
###xml 861 862 837 838 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 873 882 849 858 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig05">Fig. 5C&#8211;H</xref>
###xml 754 757 <span type="species:ncbi:272636">AAV</span>
###xml 939 942 <span type="species:ncbi:272636">AAV</span>
We next quantified CNTFRalpha immunoreactivity in Cre-expressing MNs at 2 weeks post-injection in an effort to 'catch' some of the floxed neurons after their CNTFRalpha levels are detectably depleted but before the neurons die and are lost from the analysis. Examination of over 150 Cre-positive wild-type MNs (n = 4) and over 150 Cre-positive floxed MNs (n = 4) revealed a 43% decrease in average CNTFRalpha levels in the floxed MNs (P < 0.0001) that resulted from many of the floxed MNs expressing little if any significant CNTFRalpha and others still expressing CNTFRalpha levels in the range of the wild-type MNs at this time point (Figs 6 and 7), consistent with the asynchronous initiation of Cre expression in the MNs. In contrast, 4 months after AAV-Cre injection few Cre-positive floxed MNs were found and almost all of these were CNTFRalpha-negative (n = 2; e.g. Fig. 5C-H). Considered together, the above data indicate that the AAV-Cre-infected floxed MNs begin to lose CNTFRalpha by 2 weeks after injection, and many selectively die by 1 month, with few MNs surviving long-term without CNTFRalpha.
###end p 34
###begin p 35
###xml 519 525 511 517 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig07">Fig. 7</xref>
###xml 100 103 <span type="species:ncbi:272636">AAV</span>
###xml 186 190 <span type="species:ncbi:10090">mice</span>
Examples of decreased CNTFRalpha immunoreactivity in Cre-expressing floxed facial MNs 2 weeks after AAV-Cre injection. Sections from wild-type (A, D, G) and floxed (B, E, H and C, F, I) mice immunohistochemically labeled for CNTFRalpha (red; in cytoplasm and processes of MNs) and Cre (green; in MN nuclei and, to a lesser extent, cytoplasm). Merged and individual signals from the same field are presented as columns with arrows designating examples of corresponding Cre-positive MNs. As quantitatively illustrated in Fig. 7, the Cre-expressing MNs in general display significantly reduced levels of CNTFRalpha immunoreactivity, but some still fall within the range seen with most wild-type MNs. The Cre signal includes an artifactual 'smear' that does not co-localize with other cells (based on counterstain) and, given its unidirectional nature in each field, presumably results from cell fragment displacement produced by the tissue sectioning. Scale bar, 20 mum.
###end p 35
###begin p 36
###xml 1005 1012 977 984 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 223 227 <span type="species:ncbi:10090">mice</span>
###xml 249 252 <span type="species:ncbi:272636">AAV</span>
###xml 768 772 <span type="species:ncbi:10090">mice</span>
###xml 955 959 <span type="species:ncbi:10090">mice</span>
Decreased CNTFRalpha expression in Cre-expressing floxed CNTFRalpha MNs. MetaMorph software was used to analyze CNTFRalpha immunoreactivity levels in Cre-positive facial MNs of floxed (solid bars) and wild-type (open bars) mice killed 2 weeks after AAV-Cre injection. Cre-positive MNs were randomly selected while blind to genotype, and the average intensity of cytoplasmic CNTFRalpha labeling was determined for each cell. Background values (obtained from sampling adjacent tissue) were subtracted to produce a measure of CNTFRalpha expression (in arbitrary MetaMorph-generated units). The histogram presents the percentage of MNs in each labeling intensity category. It illustrates that the overall decrease in average CNTFRalpha immunoreactivity seen in the floxed mice (see text) results from decreased CNTFRalpha immunoreactivity in at least a large fraction of the cells. The wide range of labeling intensities observed in both floxed and wild-type mice may reflect real cell to cell differences in in vivo CNTFRalpha expression, but other factors, such as the different antibody concentrations encountered by MNs at different depths from the section surface, likely also contribute significantly.
###end p 36
###begin p 37
###xml 385 386 381 382 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 396 402 392 398 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig04">Fig. 4</xref>
###xml 471 472 467 468 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 490 495 486 491 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">anova</sc>
###xml 626 627 622 623 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 165 168 <span type="species:ncbi:272636">AAV</span>
###xml 193 197 <span type="species:ncbi:10090">mice</span>
###xml 213 216 <span type="species:ncbi:272636">AAV</span>
###xml 272 276 <span type="species:ncbi:10090">mice</span>
###xml 297 300 <span type="species:ncbi:272636">AAV</span>
###xml 445 448 <span type="species:ncbi:272636">AAV</span>
###xml 533 536 <span type="species:ncbi:272636">AAV</span>
###xml 589 593 <span type="species:ncbi:10090">mice</span>
Finally, in order to examine the longer-term, CNTFRalpha-dependent survival of MNs in a context involving less Cre-related insult, we decreased the concentration of AAV-Cre by 90% and examined mice 4 months after AAV-Cre injection. As with the earlier experiments, floxed mice injected with '1/10 AAV-Cre' contained significantly less MNs than identically injected wild-type controls (P < 0.001; Fig. 4). There was no significant effect of 1/10 AAV-Cre on wild-type MNs (P > 0.05), and the anova interaction term confirmed that 1/10 AAV-Cre led to significantly more MN loss in the floxed mice than in the wild-type controls (P < 0.01).
###end p 37
###begin title 38
Discussion
###end title 38
###begin p 39
###xml 106 113 98 105 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 284 291 276 283 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 50 55 <span type="species:ncbi:10090">mouse</span>
###xml 131 134 <span type="species:ncbi:272636">AAV</span>
###xml 216 221 <span type="species:ncbi:10090">mouse</span>
###xml 393 396 <span type="species:ncbi:272636">AAV</span>
###xml 432 436 <span type="species:ncbi:10090">mice</span>
###xml 524 528 <span type="species:ncbi:10090">mice</span>
The present studies developed a floxed CNTFRalpha mouse line to conditionally disrupt the CNTFRalpha gene in vivo. In addition, an AAV-Cre vector was constructed and shown, with Cre immunohistochemistry and reporter mouse lines, to efficiently and selectively infect adult facial MNs in vivo, leading to MN Cre expression, excision of floxed gene sequence and decreased CNTFRalpha expression. AAV-Cre injection of floxed CNTFRalpha mice led to MN loss that was significantly greater than that in identically treated control mice, thereby revealing a role for endogenous CNTF receptor signaling in adult MN survival.
###end p 39
###begin p 40
###xml 510 516 494 500 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 501 522 485 506 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b6">DeChiara <italic>et al.</italic>, 1995</xref>
###xml 11 14 <span type="species:ncbi:272636">AAV</span>
###xml 41 45 <span type="species:ncbi:10090">mice</span>
###xml 162 166 <span type="species:ncbi:10090">mice</span>
###xml 322 326 <span type="species:ncbi:10090">mice</span>
###xml 401 406 <span type="species:ncbi:10090">mouse</span>
###xml 495 499 <span type="species:ncbi:10090">mice</span>
###xml 576 580 <span type="species:ncbi:10090">mice</span>
The use of AAV-Cre and floxed CNTFRalpha mice has several advantages. Most importantly, it avoids the perinatal death seen with unconditional CNTFRalpha knockout mice. Consequently, effects of CNTFRalpha gene disruption can be examined in the adult. By targeting facial MNs, that are not essential for the survival of the mice, MN loss can be followed over an extended period, while not confounded by mouse death. In contrast, the extent of MN loss observed in unconditional CNTFRalpha knockout mice (DeChiara et al., 1995) may have been limited by the premature death of the mice. Therefore, it is not possible to meaningfully compare the extent of MN loss seen with the two models. It would be interesting to directly compare the adult and embryonic requirements for CNTF receptor signaling by selectively disrupting the CNTFRalpha gene in facial MNs as they are born embryonically. Unfortunately, to the best of our knowledge, this is not technically feasible at this time.
###end p 40
###begin p 41
By initiating gene disruption in the adult, one can exclude potential development effects of gene disruption that are unrelated to ongoing adult functions. The present data indicate a role for CNTF receptor signaling in adult MN survival that is independent of any role it has in MN development or survival prior to adulthood. This promising finding is relevant to the design of any therapeutic interventions to treat adult MN diseases through manipulation of adult MN CNTF receptor signaling.
###end p 41
###begin p 42
###xml 106 112 106 112 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 97 118 97 118 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b1">Bartlett <italic>et al.</italic>, 1998</xref>
###xml 127 133 127 133 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 120 139 120 139 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b15">Kaspar <italic>et al.</italic>, 2002</xref>
###xml 147 153 147 153 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 141 159 141 159 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b16">Klein <italic>et al.</italic>, 2002</xref>
###xml 77 80 <span type="species:ncbi:272636">AAV</span>
###xml 279 282 <span type="species:ncbi:272636">AAV</span>
###xml 474 478 <span type="species:ncbi:10090">mice</span>
Consistent with previous reports showing neuron-selective infection by other AAV-2 vectors (e.g. Bartlett et al., 1998; Kaspar et al., 2002; Klein et al., 2002), the present experiments with multi-label immunohistochemistry and those with two independent reporters indicate that AAV-Cre injection of the facial nucleus leads to floxed gene excision, which is highly restricted to neurons. Therefore, these data suggest that the preferential loss of MNs in CNTFRalpha floxed mice does not result from indirect effects of disrupting CNTF receptor signaling in non-neuronal cells. Instead, it appears most likely that CNTF receptor signaling by the MNs themselves plays a role in adult MN survival. This conclusion is further supported by the Cre immunohistochemistry results that indicate that most infected, floxed MNs die while uninfected floxed MNs are not affected, contrary to what would be expected if the critical CNTF receptor signaling occurred in non-neuronal cells. In other words, it is highly unlikely that any rare, undetected, non-neuronal cells with disrupted CNTF receptors would, with the vast majority of such non-neuronal cells still functioning normally, somehow lead to the death of most of the infected MNs but not affect the uninfected MNs. This realization that CNTF receptor signaling of adult MNs is likely critical to their own survival should be another important contribution to the design of therapeutic interventions targeting CNTF receptor signaling in the adult.
###end p 42
###begin p 43
###xml 226 232 218 224 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 217 238 209 230 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b6">DeChiara <italic>et al.</italic>, 1995</xref>
###xml 339 345 331 337 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 330 351 322 343 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b31">Sendtner <italic>et al.</italic>, 1990</xref>
###xml 353 357 345 349 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b32">1992</xref>
###xml 365 371 357 363 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 359 377 351 369 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b14">Ikeda <italic>et al.</italic>, 1995</xref>
###xml 385 391 377 383 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 379 397 371 389 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b30">Sagot <italic>et al.</italic>, 1995</xref>
###xml 403 409 395 401 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 399 415 391 407 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b28">Pun <italic>et al.</italic>, 2006</xref>
###xml 755 761 747 753 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig04">Fig. 4</xref>
###xml 908 914 900 906 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 899 920 891 912 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b20">Loonstra <italic>et al.</italic>, 2001</xref>
###xml 929 935 921 927 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 922 941 914 933 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b15">Kaspar <italic>et al.</italic>, 2002</xref>
###xml 624 627 <span type="species:ncbi:272636">AAV</span>
###xml 749 753 <span type="species:ncbi:10090">mice</span>
###xml 967 971 <span type="species:ncbi:10090">mice</span>
###xml 1002 1005 <span type="species:ncbi:272636">AAV</span>
###xml 1048 1051 <span type="species:ncbi:272636">AAV</span>
###xml 1155 1159 <span type="species:ncbi:10090">mice</span>
###xml 1211 1215 <span type="species:ncbi:10090">mice</span>
###xml 1231 1234 <span type="species:ncbi:272636">AAV</span>
###xml 1365 1368 <span type="species:ncbi:272636">AAV</span>
###xml 1389 1393 <span type="species:ncbi:10090">mice</span>
###xml 1414 1417 <span type="species:ncbi:272636">AAV</span>
The CNTFRalpha-depleted MNs may die because CNTF receptors play an essential role in their survival even in the absence of insult, similar to what is observed in the embryo with the unconditional CNTFRalpha knockout (DeChiara et al., 1995). However, reports that exogenous CNTF can protect MNs from traumatic and genetic insults (Sendtner et al., 1990, 1992; Ikeda et al., 1995; Sagot et al., 1995; Pun et al., 2006) raise the additional possibility that CNTF receptor signaling may serve as an endogenous neuroprotective mechanism. The present data are also consistent with this possibility. The trauma associated with the AAV-Cre injection procedure, while insufficient to kill a significant number of normal MNs [as indicated by the PBS-injected mice (Fig. 4)], may lead to death of MNs lacking neuroprotective CNTF receptors. Similarly, chronic exposure to high Cre concentrations can be toxic (Loonstra et al., 2001; Kaspar et al., 2002). Although the wild-type mice perfused either 1 month after AAV-Cre administration or 4 months after 1/10 AAV-Cre did not display a statistically significant decrease in MNs relative to vehicle-injected wild-type mice, the data, including the values from the wild-type mice 4 months after AAV-Cre injection, suggest that the long-term exposure to Cre can challenge MNs sufficiently to kill some. The greater loss of MNs in AAV-Cre-injected floxed mice relative to that in AAV-Cre-injected controls may result from an increased vulnerability of the floxed MNs due to the loss of CNTF receptors that would otherwise help protect the cells from toxic effects of Cre.
###end p 43
###begin p 44
###xml 107 114 99 106 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 312 318 300 306 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 306 325 294 313 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b5">Davis <italic>et al.</italic>, 1993b</xref>
###xml 333 339 321 327 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 327 345 315 333 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b8">Elson <italic>et al.</italic>, 2000</xref>
###xml 355 361 343 349 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 347 367 335 355 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b7">Derouet <italic>et al.</italic>, 2004</xref>
###xml 624 630 612 618 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 617 636 605 624 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b9">Forger <italic>et al.</italic>, 2003</xref>
###xml 805 811 793 799 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 800 817 788 805 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b22">Masu <italic>et al.</italic>, 1993</xref>
We targeted CNTFRalpha because CNTFRalpha disruption is the most comprehensive approach to determining the in vivo functions of endogenous CNTF receptor signaling. Thus, CNTFRalpha is essential for all known forms of CNTF receptor signaling, regardless of the participating ligands and signaling pathways (Davis et al., 1993b; Elson et al., 2000; Derouet et al., 2004). Consequently, the present data do not address the individual ligand(s) or pathways involved in the CNTF receptor signaling that promotes adult MN survival. The CLC/CLF CNTF receptor ligand, which plays a substantial role in embryonic MN survival (Forger et al., 2003), may play a similar role in adult MN survival. CNTF may also contribute, given that unconditional disruption of the CNTF gene leads to modest MN loss with aging (Masu et al., 1993). Of course, multiple ligands may act together. Regardless, adult-onset disruption of individual ligands and pathways will be required to definitively address this issue.
###end p 44
###begin p 45
###xml 119 142 119 142 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b10">Gould &amp; Oppenheim, 2004</xref>
###xml 220 223 <span type="species:ncbi:272636">AAV</span>
Multiple endogenous growth factor systems function in a complex interaction to promote MN survival during development (Gould & Oppenheim, 2004). This is likely also the case in adulthood. In the present experiments most AAV-Cre-infected, floxed facial MNs died, such that no other endogenous growth factor mechanisms were able to save them. Therefore, it appears that, at least with the conditions and MN class involved here, adult endogenous CNTF receptor signaling plays an essential (i.e. non-redundant) role in the survival of most of the neurons.
###end p 45
###begin p 46
###xml 0 8 0 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vitro</italic>
###xml 245 252 245 252 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 357 362 <span type="species:ncbi:10090">mouse</span>
###xml 534 538 <span type="species:ncbi:10090">mice</span>
In vitro work and unconditional knockout studies have identified many signaling proteins that are involved in MN survival. The approach characterized here should help reveal which of these candidates play an essential role in adult MN survival, in vivo. As discussed above, the selective genetic manipulation of adult facial MNs, which are not required for mouse survival, allows one to identify genes critical in adult MN survival independent of developmental effects, indirect effects of other cell types and premature death of the mice.
###end p 46
###begin p 47
We thank Glenn Doerman for excellent assistance with the figures. This work was supported by National Institutes of Health grants NS35224 and NS052700 to A.J.M., and DK58193 to S.Z.
###end p 47
###begin title 48
Abbreviations
###end title 48
###begin p 49
###xml 0 22 <span type="species:ncbi:272636">adeno-associated virus</span>
adeno-associated virus
###end p 49
###begin p 50
ciliary neurotrophic factor
###end p 50
###begin p 51
CNTF receptor alpha
###end p 51
###begin p 52
Cre recombinase
###end p 52
###begin p 53
Cresyl violet
###end p 53
###begin p 54
green fluorescent protein
###end p 54
###begin p 55
leukemia inhibitory factor
###end p 55
###begin p 56
LIF receptor beta
###end p 56
###begin p 57
motor neuron
###end p 57
###begin p 58
phosphate-buffered saline
###end p 58
###begin p 59
paraformaldehyde
###end p 59
###begin title 60
References
###end title 60
###begin article-title 61
###xml 30 59 <span type="species:ncbi:10804">adeno-associated virus type 2</span>
Selective and rapid uptake of adeno-associated virus type 2 in brain
###end article-title 61
###begin article-title 62
Structural design and molecular evolution of a cytokine receptor superfamily
###end article-title 62
###begin article-title 63
Role of fibroblast growth factors in neural trauma
###end article-title 63
###begin article-title 64
Released form of CNTF receptor alpha component as a soluble mediator of CNTF responses
###end article-title 64
###begin article-title 65
LIFRbeta and gp130 as heterodimerizing signal transducers of the tripartite CNTF receptor
###end article-title 65
###begin article-title 66
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
###xml 39 43 <span type="species:ncbi:10090">mice</span>
Mice lacking the CNTF receptor, unlike mice lacking CNTF, exhibit profound motor neuron deficits at birth
###end article-title 66
###begin article-title 67
Neuropoietin, a new IL-6-related cytokine signaling through the ciliary neurotrophic factor receptor
###end article-title 67
###begin article-title 68
CLF associates with CLC to form a functional heteromeric ligand for the CNTF receptor complex
###end article-title 68
###begin article-title 69
Cardiotrophin-like cytokine/cytokine-like factor 1 is an essential trophic factor for lumbar and facial motoneurons in vivo
###end article-title 69
###begin article-title 70
The function of neurotrophic factor receptors expressed by the developing adductor motor pool in vivo
###end article-title 70
###begin article-title 71
###xml 55 60 <span type="species:ncbi:9031">chick</span>
Analysis of cell death in the trochlear nucleus of the chick embryo: calibration of the optical dissector counting method reveals systematic bias
###end article-title 71
###begin article-title 72
Trophic effect of ciliary neurotrophic factor on denervated skeletal muscle
###end article-title 72
###begin article-title 73
Stereology: a practical primer for neuropathology
###end article-title 73
###begin article-title 74
###xml 62 67 <span type="species:ncbi:10090">mouse</span>
Histometric effects of ciliary neurotrophic factor in wobbler mouse motor neuron disease
###end article-title 74
###begin article-title 75
###xml 0 22 <span type="species:ncbi:272636">Adeno-associated virus</span>
Adeno-associated virus effectively mediates conditional gene modification in the brain
###end article-title 75
###begin article-title 76
###xml 107 110 <span type="species:ncbi:10116">rat</span>
Dose and promoter effects of adeno-associated viral vector for green fluorescent protein expression in the rat brain
###end article-title 76
###begin article-title 77
Cellular delivery of trophic factors for the treatment of Huntington's disease: is neuroprotection possible?
###end article-title 77
###begin article-title 78
Essential function of LIF receptor in motor neurons
###end article-title 78
###begin article-title 79
###xml 39 42 <span type="species:ncbi:9606">man</span>
Neurotrophic factors: from molecule to man
###end article-title 79
###begin article-title 80
Growth inhibition and DNA damage induced by Cre recombinase in mammalian cells
###end article-title 80
###begin article-title 81
###xml 97 100 <span type="species:ncbi:10116">rat</span>
Immunohistochemical localization of ciliary neurotrophic factor receptor alpha expression in the rat nervous system
###end article-title 81
###begin article-title 82
Disruption of the CNTF gene results in motor neuron degeneration
###end article-title 82
###begin article-title 83
###xml 41 46 <span type="species:ncbi:9606">human</span>
###xml 78 86 <span type="species:ncbi:9606">patients</span>
Toxicity and tolerability of recombinant human ciliary neurotrophic factor in patients with amyotrophic lateral sclerosis
###end article-title 83
###begin article-title 84
###xml 7 29 <span type="species:ncbi:272636">adeno-associated virus</span>
Use of adeno-associated virus as a general transduction vector for mammalian cells
###end article-title 84
###begin article-title 85
###xml 24 29 <span type="species:ncbi:10090">mouse</span>
Z/EG, a double reporter mouse line that expresses enhanced green fluorescent protein upon cre-mediated excision
###end article-title 85
###begin article-title 86
Control of embryonic motoneuron survival in vivo by ciliary neurotrophic factor
###end article-title 86
###begin article-title 87
###xml 42 64 <span type="species:ncbi:272636">adeno-associated virus</span>
###xml 66 69 <span type="species:ncbi:272636">AAV</span>
Gene therapy of Parkinson's disease using adeno-associated virus (AAV) vectors
###end article-title 87
###begin article-title 88
Selective vulnerability and pruning of phasic motoneuron axons in motoneuron disease alleviated by CNTF
###end article-title 88
###begin article-title 89
CNTF variants with increased biological potency and receptor selectivity define a functional site of receptor interaction
###end article-title 89
###begin article-title 90
###xml 146 151 <span type="species:ncbi:10090">mouse</span>
Polymer encapsulated cell lines genetically engineered to release ciliary neurotrophic factor can slow down progressive motor neuronopathy in the mouse
###end article-title 90
###begin article-title 91
Ciliary neurotrophic factor prevents the degeneration of motor neurons after axotomy
###end article-title 91
###begin article-title 92
###xml 70 75 <span type="species:ncbi:10090">mouse</span>
Ciliary neurotrophic factor prevents degeneration of motor neurons in mouse mutant progressive motor neuronopathy
###end article-title 92
###begin article-title 93
###xml 12 16 12 16 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lacZ</italic>
Generalized lacZ expression with the ROSA26 Cre reporter strain
###end article-title 93
###begin article-title 94
Construction of gene targeting vectors from lambdaKOS genomic libraries
###end article-title 94
###begin article-title 95
Brain injury and repair mechanisms: the potential for pharmacologic therapy in closed-head trauma
###end article-title 95
###begin article-title 96
###xml 12 34 <span type="species:ncbi:272636">adeno-associated virus</span>
Recombinant adeno-associated virus purification using novel methods improves infectious titer and yield
###end article-title 96
###begin title 97
Supplementary material
###end title 97
###begin p 98
The following supplementary material may be found on 
###end p 98
###begin p 99
###xml 37 40 37 40 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 0 3 <span type="species:ncbi:272636">AAV</span>
###xml 51 55 <span type="species:ncbi:10090">mice</span>
###xml 224 227 <span type="species:ncbi:272636">AAV</span>
AAV-Cre-infected facial MNs in ROSA26+/-) reporter mice display discontinuous 'specs' of Xgal reporter staining in their processes, in addition to the much more intense soma labeling. Highmagnification photomicrograph of an AAV-Cre-infected facial MN (from experiment as in Fig. 2C).
###end p 99
###begin p 100
###xml 11 18 11 18 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="SD1">Fig. S1</xref>
Similar to Fig. S1.
###end p 100
###begin p 101
###xml 11 18 11 18 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="SD1">Fig. S1</xref>
Similar to Fig. S1.
###end p 101
###begin p 102
###xml 11 18 11 18 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="SD1">Fig. S1</xref>
Similar to Fig. S1.
###end p 102
###begin p 103
###xml 61 64 61 64 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 74 78 <span type="species:ncbi:10090">mice</span>
Cre expression in non-neuronal facial nucleus cells of ROSA26+/- reporter mice is clearly detected as distinctive Xgal staining.
###end p 103
###begin p 104
###xml 71 74 71 74 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 84 89 <span type="species:ncbi:10090">mouse</span>
Floxed gene excision detected in presumptive oligodendrocytes of ROSA26+/- reporter mouse.
###end p 104
###begin p 105
Please note: Blackwell publishing are not responsible for the content or functionality of any supplementary materials supplied by the authors. Any queries (other than missing material) should be directed to the correspondence author for the article.
###end p 105

